Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says - CNBC
- Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says CNBC
- Ozempic predecessor suggests potential for GLP-1 drugs in Alzheimer’s in early trial CNN
- Novo's older obesity drug shows biological effect on Alzheimer's patients in small trial Reuters
- Can Weight Loss Drugs Like Ozempic Protect Brains And Stave Off Alzheimer’s? New Research Suggests They Can. Forbes